Literature DB >> 9576013

A novel murine model of allergic conjunctivitis.

M T Magone1, C C Chan, L V Rizzo, A T Kozhich, S M Whitcup.   

Abstract

Allergic conjunctivitis affects over 40 million patients per year in the United States. Here we present the first murine model that incorporates the clinical, cellular, and humoral parameters of allergic conjunctivitis, including a ragweed-induced Th2-type cytokine production by lymphocytes. SWR/J mice were immunized with short ragweed pollen in aluminum hydroxide. Ten days after immunization, allergic conjunctivitis was induced by one topical application of ragweed pollen onto the eye. Immediate response was characterized by chemosis, redness of the conjuctiva, and lid edema. Histopathology and immunohistochemistry showed dense conjunctival infiltration with polymorphonuclear leukocytes, macrophages, and CD4+ T lymphocytes. In addition, ragweed-specific IgG1 and IgE serum levels were significantly higher in immunized animals, and high levels of IL-4 and IL-5 were detected in supernatants from ragweed-activated lymphocytes. This reproducible model is a well-suited instrument for testing the pathophysiology and future therapies of allergic conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576013     DOI: 10.1006/clin.1997.4507

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  26 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model.

Authors:  Xin Chen; Ruzhi Deng; Wei Chi; Xia Hua; Fan Lu; Fang Bian; Ning Gao; Zhijie Li; Stephen C Pflugfelder; Cintia S de Paiva; De-Quan Li
Journal:  Allergy       Date:  2019-01-04       Impact factor: 13.146

3.  NKT cells are necessary for maximal expression of allergic conjunctivitis.

Authors:  Nancy J Reyes; Elizabeth Mayhew; Peter W Chen; Jerry Y Niederkorn
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

Review 4.  Animal models of high-risk corneal transplantation: A comprehensive review.

Authors:  Rohan Bir Singh; Anna Marmalidou; Afsaneh Amouzegar; Yihe Chen; Reza Dana
Journal:  Exp Eye Res       Date:  2020-07-25       Impact factor: 3.467

5.  Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis.

Authors:  Akemi Ozaki; Atsuki Fukushima; Kazuyo Fukata; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-04       Impact factor: 3.117

6.  Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis.

Authors:  Attila Bacsi; Nilesh Dharajiya; Barun K Choudhury; Sanjiv Sur; Istvan Boldogh
Journal:  J Allergy Clin Immunol       Date:  2005-08-19       Impact factor: 10.793

7.  Short ragweed pollen promotes M2 macrophage polarization via TSLP/TSLPR/OX40L signaling in allergic inflammation.

Authors:  Ruzhi Deng; Xin Chen; Yun Zhang; Fang Bian; Ning Gao; Jiaoyue Hu; Changjun Wang; Rodrigo G de Souza; Fan Lu; Stephen C Pflugfelder; De-Quan Li
Journal:  Mucosal Immunol       Date:  2019-07-26       Impact factor: 7.313

8.  Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways.

Authors:  De-Quan Li; Lili Zhang; Stephen C Pflugfelder; Cintia S De Paiva; Xiaobo Zhang; Guiqiu Zhao; Xiaofen Zheng; Zhitao Su; Yangluowa Qu
Journal:  J Allergy Clin Immunol       Date:  2011-08-06       Impact factor: 10.793

9.  Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease.

Authors:  R E Smith; N J Reyes; P Khandelwal; S L Schlereth; H S Lee; S Masli; D R Saban
Journal:  J Leukoc Biol       Date:  2016-02-08       Impact factor: 4.962

10.  SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

Authors:  Jonathan C Poe; Wei Jia; Julie A Di Paolo; Nancy J Reyes; Ji Yun Kim; Hsuan Su; John S Sundy; Adela R Cardones; Victor L Perez; Benny J Chen; Nelson J Chao; Diana M Cardona; Daniel R Saban; Stefanie Sarantopoulos
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.